Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s efforts to hold industry accountable for fulfilling critical post-marketing studies of the benefits, safety of new drugs

The FDA is committed to making sure post-market studies are transparent to the public and that industry is fulfilling their PMRs and PMCs.

Original source: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626090.htm

Related Posts